OTC Markets OTCPK - Delayed Quote • USD Haleon plc (HLNCF) Follow Compare 4.5220 0.0000 (0.00%) At close: January 10 at 3:00:00 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Haleon (LON:HLN) Is Experiencing Growth In Returns On Capital Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key... TUMS Teams Up with DraftKings to Launch TUMS Fantasy Foodball Pool, Making Gameday Food Dreams a Reality As hundreds of millions prepare to tune into the biggest day in football, a new survey from TUMS has revealed that 1 in 4 viewers will be focused on the real MVP: the food.* To celebrate gameday foodies, TUMS has teamed up with DraftKings to launch TUMS Fantasy Foodball Pool, a first-of-its-kind free online game where players can create a lineup made entirely of their favorite food and drink combinations. No matter the plate – fantasy or real – TUMS provides fast relief when occasional heartburn This Money Manager Likes Gold as a Hedge Against Disaster. How Nations’ Debts Put Markets at Risk. First Eagle’s Matthew McLennan shares some of his favorite stocks, including Oracle and Meta, and his biggest investment fears. Why sovereign risk looms large in the coming decade. What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday? Pfizer Inc. (NYSE:PFE) will conduct an investor call on Tuesday to provide full-year 2025 financial guidance. Ahead of the call, Goldman Sachs has outlined its expectations for the guide and commentary on the upcoming year. The analyst anticipates that Pfizer’s management will guide to EPS in the mid-to-high $2 range with core business growth offset by the $0.30 in favorable but non-recurring items during 2024. Pfizer highlighted several factors affecting its 2024 EPS that won’t carry over to 20 Haleon Welcomes Joe Sta-Romana as Chief Customer Officer to Lead US Growth and Transformation Haleon, a world-leading consumer health company, is pleased to announce the appointment of Joe Sta-Romana as Chief Customer Officer (CCO) for its US business, effective December 1, 2024. In this role, Joe will lead the organization's customer strategy, driving growth and transformation in the US market. Can Mixed Financials Have A Negative Impact on Haleon plc's 's (LON:HLN) Current Price Momentum? Most readers would already know that Haleon's (LON:HLN) stock increased by 3.9% over the past week. However, we decided... Haleon plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions Haleon plc ( LON:HLN ) came out with its third-quarter results last week, and we wanted to see how the business is... Haleon Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag Haleon ( LON:HLN ) Third Quarter 2024 Results Key Financial Results Revenue: UK£2.78b (flat on 3Q 2023). Net income... Friday's FTSE 100 risers and fallers: Tesco, Frasers and EasyJet Investor updates on the companies trending on the UK blue-chip index on Friday. 3 Factors That Make Pfizer's Ultra-High-Yield Dividend Safer Than You Might Think Pfizer's dividends should keep flowing and growing. Haleon Backs Guidance Despite Revenue, Profit Miss Haleon backed its full-year guidance despite lower third-quarter revenue and earnings, although organic revenue growth of 6.1% topped its own forecasts. Stocks to watch this week: BP, Shell, Uber, HSBC and Intel Earnings preview of key companies reporting this week and what to look out for. Haleon plc (LON:HLN) is largely controlled by institutional shareholders who own 72% of the company Key Insights Significantly high institutional ownership implies Haleon's stock price is sensitive to their trading... Haleon Canada Donates Children's Advil to Organizations in Need Haleon (Canada), a global leader in consumer health, announced today a donation of over 280,000 bottles of Children's Advil to two Canadian-based, non-profit organizations. This donation supports Haleon's purpose and is helping to ensure no child is left with untreated fever or pain. HLN or PODD: Which Is the Better Value Stock Right Now? HLN vs. PODD: Which Stock Is the Better Value Option? Haleon Announces Leadership Transition in Canada: Rupa Bahri to Depart, Christine Jakovcic Appointed as New General Manager Haleon, a global leader in consumer health, today announced the appointment of Christine Jakovcic as General Manager, Haleon Canada. This appointment follows Rupa Bahri stepping down after a distinguished 13-year career with the company to pursue other interests. Over the past six years, Rupa's leadership has been pivotal in elevating the Canadian business, achieving exceptional growth, and nurturing an inclusive, engaged company culture. Pfizer offloads $3.3 billion stake in Sensodyne-maker Haleon Pfizer offloaded shares worth roughly $3.26 billion in Haleon at 380 pence apiece, cutting its stake to 15% in the world's largest standalone consumer healthcare firm, a bookrunner said on Tuesday. Drug giant Pfizer sells $3.3 billion stake in Sensodyne-maker Haleon (Reuters) -Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.6%. Shares in Haleon, which was created by the merger of GSK and Pfizer's consumer healthcare businesses in 2019 and spun off from the British drugmaker in 2022, fell 1.2% to 388 pence in morning trade on Tuesday. The Pfizer shares were placed at 380 pence each, a discount of 3.3% to Haleon's last closing price. Haleon (LSE:HLN) Eyes Bolt-On M&A and New Product Launches to Drive Growth Despite High Valuation Concerns Haleon (LSE:HLN) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a 4.1% organic sales growth in Q2 2024 and the launch of new products, contrasted by a 4.4% decline in the over-the-counter pain relief category and regulatory risks. In the discussion that follows, we will delve into Haleon's financial health, operational inefficiencies, strategic growth initiatives, and external threats to provide a comprehensive overview of the... Estimating The Fair Value Of Haleon plc (LON:HLN) Key Insights Using the 2 Stage Free Cash Flow to Equity, Haleon fair value estimate is UK£3.38 Haleon's UK£3.87 share... Performance Overview Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is FTSE 100 Return HLNCF FTSE 100 YTD -5.99% +1.57% 1-Year +7.79% +7.35% 3-Year +29.94% +10.20%